Background The value of alpha-fetoprotein (AFP) as a prognostic indicator in patients with
hepatocellular carcinoma (HCC) has been proposed in recent studies, but the evidence so …

Background The clinical value of alpha-fetoprotein (AFP) in patients with AFP-negative (< 20
ng/ml) hepatocellular carcinoma (HCC) who underwent curative resection remained …

Background Serum alpha-fetoprotein (AFP) is frequently used to predict posthepatectomy
outcomes in patients with hepatocellular carcinoma (HCC), but its predictive value is still not …

UICC staging) and tumor size. Although this study is retrospective, it is of interest both by the
issue raised which is still contradictory and by the large size of the cohort studied by the …

Background To investigate the prediction value of preoperative serum alpha-fetoprotein
(AFP) level for the prognosis of hepatocellular carcinoma (HCC), by comparing pathological …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

AIM To investigate whether the change in pre-/post-operation serum alpha-fetoprotein (AFP)
levels is a predictive factor for hepatocellular carcinoma (HCC) outcomes. METHODS We …

Background While the majority of studies report that a raised serum α-fetoprotein (AFP) level
before operation is associated with a high risk of recurrence and death in patients who …

AIMS: Alpha-fetoprotein (AFP) loses its potentials in treatment evaluation and prognosis
prediction in patients with AFP negative (≤ 20 ng/ml) hepatocellular carcinoma (HCC). The …

Background Assessing the outcomes of surgeries for hepatocellular carcinoma (HCC)
patients who exceed the Milan criteria is necessary. Some studies have demonstrated that …